T82.827
Fibrosis due to cardiac prosthetic devices, implants and grafts
Clinical Classification Guidelines
Medical Intelligence & Overview
Fibrosis related to cardiac prosthetic devices, implants, and grafts, coded as T82.827 in the ICD-10, refers to the formation of excessive fibrous connective tissue around these medical devices. This condition can develop following heart surgeries that involve the use of artificial valves, pacemaker leads, or other implants. While these devices are crucial for managing various heart conditions, fibrosis can sometimes pose challenges to device function and overall heart health. Recognizing and understanding this condition is important for individuals with cardiac implants and their healthcare providers.
Causes & Symptoms
Clinical Causes: Foreign material inciting an immune response Chronic inflammation around the device Healing process following device implantation Mechanical stress exerted by the implant Infection leading to tissue changes Individual susceptibility to fibrotic reactions
Key Symptoms: Reduced device effectiveness or malfunction Discomfort or pain near the implant site Swelling or thickening around the implant area Palpitations or irregular heart rhythms Signs of infection, such as redness or warmth Symptoms indicating compromised heart function
Diagnostic & Treatment
Diagnosis Path: Diagnosis of fibrosis due to cardiac devices typically involves a combination of clinical evaluation and diagnostic tests. Imaging modalities such as echocardiography, MRI, or CT scans can reveal fibrotic tissue formation. Additionally, assessments of device function and patient symptoms help in determining the impact of fibrosis. Sometimes, tissue biopsies may be performed to confirm fibrosis and exclude other causes of tissue pathology.
Treatment Protocols: Monitoring device function regularly to detect any issues early Medications to control symptoms or reduce inflammation Surgical intervention to remove or replace devices if fibrosis causes significant problems Physiotherapy and supportive care for cardiac function Antifibrotic therapies, though research in this area is ongoing Preventive measures include meticulous surgical technique and post-implantation care
Clinical Advice & FAQs
Billing Guidance
Is T82.827 a billable ICD-10 code?
Yes, T82.827 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T82.827?
Clinical documentation must specify the nature of Fibrosis due to cardiac prosthetic devices, implants and grafts and any associated comorbidities for accurate reporting.
Cite this Clinical Reference